Results 71 to 80 of about 2,801 (152)

Obicetrapib: There is still Life in the CETP Inhibitor! [PDF]

J Atheroscler Thromb
Ogura M.
europepmc   +1 more source

<i>Proprotein Convertase Subtilisin</i>/<i>Kexin Type 9</i> (<i>PCSK9</i>) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia. [PDF]

Int J Mol Sci
Woźniak E, Woźniak A, Pawlos A, Broncel M, Satała J, Bukowska B, Gorzelak-Pabiś P.   +6 more
europepmc   +1 more source

Safety and Efficacy of Moringa oleifera Lamarck (1785) — Therapeutic and Toxicological Properties [PDF]

, 2014
Aires Forte Pinheiro, Jaksilania, Buenos Aires Pereira, Janiella, de Abreu, Maria Carolina, de Jesus Costa, Nagilla Daniela, do Nascimento Silva, Jurandy, Ferreira de Araújo, Éverton José, Ferreira de Carvalho Oliveira, Samara, Mendes de Freitas, Rivelilson, Pessoa, Cláudia, Pinheiro Ferreira, Paulo Michel   +9 more
core   +2 more sources

Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis. [PDF]

Ann Med
Albawa'neh AS, Alqasrawi MN, Al-Mahayri ZN, Albawaana A, Ahmed G, Al-Rifai RH, Ali BR.   +6 more
europepmc   +1 more source

Effect of evolocumab on the gut microbiota in patients with acute myocardial infarction. [PDF]

J Med Microbiol
Zou J, Peng Y, Cai H, Zhong Q, Zhu N, Gu W, Yang F, Shi T, Yang S, Chen L.   +9 more
europepmc   +1 more source

Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy. [PDF]

Eur Heart J Qual Care Clin Outcomes
Engebretsen I, Ødegaard KM, Halvorsen S, Bugge C, Kristiansen IS, Støvring H, Munkhaugen J.   +6 more
europepmc   +1 more source

Treatment pathways of lipid-lowering therapies in Germany 2016-2022. [PDF]

Clin Res Cardiol
Katzmann JL, Grellmann C, Leppert B, Müller-Kozarez I, Schulz M, Laufs U.   +5 more
europepmc   +1 more source

Achieving LDL-Cholesterol Goals: Can Implementation Science Save Us? [PDF]

Arq Bras Cardiol
Cesena FY.
europepmc   +1 more source

Rosuvastatina e ciprofibrato no tratamento da dislipidemia em pacientes com HIV [PDF]

Albert Schiaveto de Souza, Anamaria Mello Miranda Paniago, Hamilton Domingos, João Américo Domingos, Renata London Rodrigues, Rivaldo Venâncio da Cunha   +5 more
core   +1 more source

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study). [PDF]

Diabetes Obes Metab
Hong S, Kim WJ, Kim S, Park JH, Kang ES, Moon MK, Kim JT, Mok JO, Lee KY, Park CY, Lee CB.   +10 more
europepmc   +1 more source